AGRX - アジャイル・セラピュ―ティクス （Agile Therapeutics Inc.） アジャイル・セラピュ―ティクスAGRXのチャート
AGRXの企業情報
| symbol | AGRx |
|---|---|
| 会社名 | Agile Therapeutics Inc （アジャイル・セラピュ―ティクス） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Major Pharmaceuticals |
| 業種 | バイオテクノロジ―_メディカルリサ―チ 医療関連（Health Care） |
| 概要 | 事業概要 アジャイル・セラピューティクス（Agile Therapeutics Inc.）は女性の健康向けスペシャリティ医薬品企業。同社は、新規処方避妊製品の開発と商業化に焦点を当てる。同社の製品候補は、利便性を提供し、コンプライアンスを促進する避妊オプションを女性に提供するために設計される。同社のリード製品候補の「Twirla」はまた「AG200-15」として知られ、フェーズⅢ臨床開発にある週一回の処方避妊パッチである。「Twirla」は、利用可能なパッチを上回る利点を提供するように設計され、パッチの密着性・安定性と患者の快適性を最適化するように意図される「Skinfusion」という経皮パッチ技術に基づく。「Twirla」は、プロゲスチンの一種の合成ステロイドホルモンであるレボノルゲストレル（LNG）、及び合成エストロゲンである有効成分のエチニルエストラジオール（EE）を含有する複合ホルモン避妊薬（CHC）パッチである。 アジャイル・セラピュ―ティクスは、女性のヘルスケア製品に特化した米国の医薬品開発会社。新規処方避妊製品の開発と商業化に注力する。避妊用の経皮パッチ技術「スキンフュ―ジョン」を研究・開発する。同社の製品候補である避妊パッチ「Twirla(別名AG200-15)」は、避妊を選択する女性に利便性を提供し、迎合性を容易にする。 Agile Therapeutics is a forward-looking women's healthcare company dedicated to fulfilling the unmet health needs of today's women. Its product and product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. The Company's initial product, Twirla®, (levonorgestrel and ethinyl estradiol), a transdermal system, is a non-daily prescription contraceptive. Twirla is based on Company's proprietary transdermal patch technology, called Skinfusion®, which is designed to allow drug delivery through the skin. The Company may occasionally disseminate material, nonpublic information on the Company's website. |
| 本社所在地 | 101 Poor Farm Road Princeton NJ 08540 USA |
| 代表者氏名 | Alfred Altomari アルフレッドアルトマリ |
| 代表者役職名 | Chairman of the Board President Chief Executive Officer 取締役会長兼最高経営責任者（CEO） |
| 電話番号 | +1 609-683-1880 |
| 設立年月日 | 35765 |
| 市場名 | NASDAQ National Market System |
| ipoyear | 2014年 |
| 従業員数 | － |
| url | www.agiletherapeutics.com |
| nasdaq_url | https://www.nasdaq.com/symbol/agrx |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -24.44100 |
| 終値（lastsale） | 0.46 |
| 時価総額（marketcap） | 15813571.34 |
| 時価総額 | 時価総額（百万ドル） 24.40790 |
| 売上高 | 売上高（百万ドル） 0.00000 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 9.46790 |
| 当期純利益 | 当期純利益（百万ドル） -25.51900 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Agile Therapeutics Inc revenues was not reported. Net loss decreased 19% to $12.2M. Lower net loss reflects Other Research and Development decrease of 28% to $5.7M (expense) Other General and administrative decrease of 10% to $4M (expense) Interest expense decrease of 34% to $688K (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$0.52 to -$0.36. |
AGRXのテクニカル分析
AGRXのニュース
How did Agile Therapeutics Inc. (AGRX) fare last session? 2023/02/07 14:40:00 US Post News
Agile Therapeutics Inc. (NASDAQ:AGRX) closed Monday at $0.27 per share, up from $0.27 a day earlier. While Agile Therapeutics Inc. has overperformed by 1.42%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, AGRX fell by -98.00%, with highs and lows ranging from $15.20 to $0.17, whereas […]
Here’s the Things Nobody Tells You About: Science 37 Holdings, Inc. (NASDAQ:SNCE 15.18%), Agile Therapeutics, Inc. (NASDAQ:AGRX 1.85%) 2023/02/03 12:59:37 Stock Equity
SNCE has seen its SMA50 which is now 23.80%. In looking the SMA 200 we see that the stock has seen a -66.61%. AGRX has seen its SMA50 which is … The post Here’s the Things Nobody Tells You About: Science 37 Holdings, Inc. (NASDAQ:SNCE 15.18%), Agile Therapeutics, Inc. (NASDAQ:AGRX 1.85%) appeared first on Stocks Equity .
This stocks will boost Up Your investment: Troika Media Group, Inc. (NASDAQ:TRKA -2.40%), Agile Therapeutics, Inc. (NASDAQ:AGRX 4.52%) 2023/02/02 17:42:37 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post This stocks will boost Up Your investment: Troika Media Group, Inc. (NASDAQ:TRKA -2.40%), Agile Therapeutics, Inc. (NASDAQ:AGRX 4.52%) appeared first on Stocks Equity .
Enthralling stocks: Ensysce Biosciences, Inc. (NASDAQ:ENSC 2.71%), Agile Therapeutics, Inc. (NASDAQ:AGRX 1.60%) 2023/01/30 17:26:36 Stock Equity
ENSC has seen its SMA50 which is now -46.28%. In looking the SMA 200 we see that the stock has seen a -90.72%. AGRX has seen its SMA50 which is … The post Enthralling stocks: Ensysce Biosciences, Inc. (NASDAQ:ENSC 2.71%), Agile Therapeutics, Inc. (NASDAQ:AGRX 1.60%) appeared first on Stocks Equity .
Agile stock rises as 2023 revenue seen up to $30M 2023/01/09 13:46:30 Seeking Alpha
Agile Therapeutics (AGRX) said it expects full year 2023 net revenue to be in the range of $25M to $30M.Birth control patch Twirla factory sales for Q4 2022 are expected to be about…
Results from Agile Therapeutics Inc. (AGRX) show risk 2022/09/26 13:32:00 US Post News
Agile Therapeutics Inc. (NASDAQ:AGRX) closed Friday at $0.28 per share, down from $0.30 a day earlier. While Agile Therapeutics Inc. has underperformed by -8.12%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, AGRX fell by -99.32%, with highs and lows ranging from $42.00 to $0.28, whereas […]
Agile Therapeutics Inc. (NASDAQ:AGRX) Shares Are Down -13.33% From The Lows, But Can They Stay Up? 2022/09/23 15:00:00 Marketing Sentinel
In last trading session, Agile Therapeutics Inc. (NASDAQ:AGRX) saw 2.37 million shares changing hands with its beta currently measuring 1.21. Company’s recent per share price level of $0.30 trading at -$0.04 or -11.20% at ring of the bell on the day assigns it a market valuation of $65.76M. That closing price of AGRX’s stock is … Agile Therapeutics Inc. (NASDAQ:AGRX) Shares Are Down -13.33% From The Lows, But Can They Stay Up? Read More »
What To Expect As Agile Therapeutics Inc. (NASDAQ: AGRX) Delivers An -95.92% Loss In 6 Months 2022/09/15 15:30:00 Marketing Sentinel
During the last session, Agile Therapeutics Inc. (NASDAQ:AGRX)’s traded shares were 1.64 million, with the beta value of the company hitting 1.22. At the end of the trading day, the stock’s price was $0.39, reflecting an intraday loss of -3.14% or -$0.02. The 52-week high for the AGRX share is $44.00, that puts it down … What To Expect As Agile Therapeutics Inc. (NASDAQ: AGRX) Delivers An -95.92% Loss In 6 Months Read More »
Agile Therapeutics (AGRX) presents at H.C. Wainwright 24th Annual Global Investment Conference - Slideshow (NASDAQ:AGRX) 2022/09/14 13:43:02 Seeking Alpha
The following slide deck was published by Agile Therapeutics, Inc.
The Agile Therapeutics Inc. (AGRX) had a good session last reading, didn’t it? 2022/09/13 14:00:00 US Post News
The share price of Agile Therapeutics Inc. (NASDAQ:AGRX) fell to $0.39 per share on Monday from $0.40. While Agile Therapeutics Inc. has underperformed by -2.88%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, AGRX fell by -99.17%, with highs and lows ranging from $50.40 to $0.37, […]
Agile Therapeutics to Report Second Quarter 2022 Financial Results and Provide Business Update on Thursday, August 11, 2022 2022/07/28 12:05:00 GlobeNewswire
Live Conference Call and Webcast at 4:30 p.m. ET Live Conference Call and Webcast at 4:30 p.m. ET
Outrageous stocks: Agile Therapeutics, Inc. (NASDAQ:AGRX 2.71%), Party City Holdco Inc. (NYSE:PRTY -9.13%) 2022/07/27 00:40:05 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Outrageous stocks: Agile Therapeutics, Inc. (NASDAQ:AGRX 2.71%), Party City Holdco Inc. (NYSE:PRTY -9.13%) appeared first on Stocks Equity .
Maxim Group Upgrades Agile Therapeutics to Buy 2022/07/26 11:56:04 Investing.com
https://www.investing.com/news/pro/maxim-group-upgrades-agile-therapeutics-to-buy-432SI-2853994
Agile Therapeutics Inc. (NASDAQ:AGRX) Is 11.67% Above Its 52-Week Low, But How Long Will It Remain So? 2022/07/22 15:30:00 Marketing Sentinel
In last trading session, Agile Therapeutics Inc. (NASDAQ:AGRX) saw 8.48 million shares changing hands with its beta currently measuring 1.61. Company’s recent per share price level of $0.60 trading at $0.01 or 1.86% at ring of the bell on the day assigns it a market valuation of $7.83M. That closing price of AGRX’s stock is … Agile Therapeutics Inc. (NASDAQ:AGRX) Is 11.67% Above Its 52-Week Low, But How Long Will It Remain So? Read More »
Agile Therapeutics Inc. (NASDAQ: AGRX) Is Down -5.17% From Its 52-Week Low; YTD, It Is Down -97.03% – What To Do Now 2022/07/15 14:00:00 Marketing Sentinel
During the last session, Agile Therapeutics Inc. (NASDAQ:AGRX)’s traded shares were 9.94 million, with the beta value of the company hitting 1.52. At the end of the trading day, the stock’s price was $0.58, reflecting an intraday loss of -9.62% or -$0.06. The 52-week high for the AGRX share is $53.20, that puts it down … Agile Therapeutics Inc. (NASDAQ: AGRX) Is Down -5.17% From Its 52-Week Low; YTD, It Is Down -97.03% – What To Do Now Read More »